Credit Suisse lifted its share-price targets for GlaxoSmithKline, AstraZeneca, and Shire, saying it expects the pharma sector to be something of a port in a storm for investors worried about the economy. Report [1]
Links:
[1] http://www.sharecast.com/cgi-bin/sharecast/story.cgi?story_id=1843726